100
Participants
Start Date
October 1, 2023
Primary Completion Date
October 1, 2026
Study Completion Date
October 1, 2026
Insertable subcutaneous cardiac monitor (BIOMONITOR IIIm®, Biotronik®)
Implantation of a subcutaneous cardiac monitor (BIOMONITOR IIIm®, Biotronik®) before beginning the Bruton's tyrosine kinase inhibitor treatment.
Caen University Hospital, Department of Pharmacology, Caen
University Hospital, Marseille
OTHER
Groupe Hospitalier Pitie-Salpetriere
OTHER
European Georges Pompidou Hospital
OTHER
Hôpital Necker-Enfants Malades
OTHER
Saint Antoine University Hospital
OTHER
Hospices Civils de Lyon
OTHER
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Biotronik SE & Co. KG
INDUSTRY
University Hospital, Caen
OTHER